Clinical Trial Update: Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and efficacy of SR121463B in patients with Syndrome of inappropriate antidiuretic hormone secretion (SIADH) complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia
• Syndrome of Inappropriate Antidiuretic Hormone Secretion

Drugs mentioned

• SR121463B

Snippet

Sponsor: Sanofi | Conditions: Inappropriate ADH Syndrome, Hyponatremia | Phase 3 | Status: COMPLETED